Holen Sie sich die Stockscreener-App
6.50
0.76%
-0.05
Schlusskurs vom Vortag:
$6.55
Offen:
$6.56
24-Stunden-Volumen:
47,267
Relative Volume:
0.41
Marktkapitalisierung:
$178.31M
Einnahmen:
$21.25M
Nettoeinkommen (Verlust:
$-16.05M
KGV:
-10.66
EPS:
-0.61
Netto-Cashflow:
$-17.14M
1W Leistung:
+4.33%
1M Leistung:
+2.85%
6M Leistung:
+0.46%
1J Leistung:
-34.93%
1-Tages-Spanne:
$6.40
$6.64
1-Wochen-Bereich:
$6.17
$6.78
52-Wochen-Spanne:
$3.96
$11.49
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Firmenname
Fennec Pharmaceuticals Inc
Sektor
Branche
Telefon
(919) 636-4530
Adresse
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Vergleichen Sie FENC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
6.50 | 178.31M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-22 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | Eingeleitet | CapitalOne | Overweight |
| 2022-08-08 | Fortgesetzt | Craig Hallum | Buy |
| 2020-06-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-10-11 | Eingeleitet | Goldman | Buy |
Fennec Pharmaceuticals Inc Aktie (FENC) Neueste Nachrichten
Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Above Fifty Day Moving AverageShould You Sell? - MarketBeat
Fennec PharmaA Sound Investment? - RTTNews
Fennec Pharmaceuticals (NASDAQ:FENC) shareholder returns have been respectable, earning 41% in 3 years - Simply Wall St
Fennec Pharmaceuticals (NASDAQ:FENC) versus CARGO Therapeutics (NASDAQ:CRGX) Financial Survey - Defense World
Fennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
Barclays PLC Raises Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Sees Large Decrease in Short Interest - MarketBeat
Learn to Evaluate (FENC) using the Charts - Stock Traders Daily
Fennec Pharmaceuticals Inc. (TSE:FRX) Director Sells C$87,552.00 in Stock - MarketBeat
Barclays PLC Grows Position in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) Stock - MarketBeat
Fennec Pharmaceuticals director Raykov Rosty sells $60,800 in shares By Investing.com - Investing.com Australia
Fennec Pharmaceuticals director Raykov Rosty sells $60,800 in shares - Investing.com
Franklin Resources Inc. Has $74,000 Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
State Street Corp Has $1.64 Million Stake in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals (TSE:FRX) Shares Pass Above 50 Day Moving AverageShould You Sell? - MarketBeat
Stocks In Play: Fennec Pharmaceuticals Inc. - Barchart
(FENC) Trading Advice - Stock Traders Daily
Wedbush Raises Earnings Estimates for Fennec Pharmaceuticals - Defense World
Q4 EPS Estimate for Fennec Pharmaceuticals Raised by Analyst - MarketBeat
Wedbush Issues Optimistic Outlook for TSE:FRX Earnings - Defense World
Equities Analysts Issue Forecasts for TSE:FRX Q3 Earnings - MarketBeat
Fennec Pharmaceuticals Announces Pedmarqsi Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales - Marketscreener.com
Fennec Pharmaceuticals Inc. (TSE:FRX) Director Acquires C$96,840.00 in Stock - MarketBeat
Fennec Pharmaceuticals’ (FENC) Outperform Rating Reiterated at Wedbush - Defense World
Fennec's Pedmarqsi gets nod from U.K. regulators - MSN
Long Term Trading Analysis for (FENC) - Stock Traders Daily
Fennec Pharmaceuticals (NASDAQ:FENC) Receives Outperform Rating from Wedbush - MarketBeat
Fennec Pharmaceuticals Inc. - Baystreet.ca
Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales - The Manila Times
Fennec's PEDMARQSI® Breakthrough: First NHS Treatment for Child Cancer-Related Hearing Loss - StockTitan
HC Wainwright Issues Negative Forecast for TSE:FRX Earnings - Defense World
What is HC Wainwright’s Forecast for FENC FY2024 Earnings? - Defense World
FY2024 Earnings Estimate for TSE:FRX Issued By HC Wainwright - MarketBeat
What is HC Wainwright's Estimate for FENC FY2024 Earnings? - MarketBeat
Fennec Pharmaceuticals partially repays its outstanding convertible debt facility - MSN
Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management - The Manila Times
Verition Fund Management LLC Sells 23,113 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals' (FENC) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Shares Sold by BNP Paribas Financial Markets - Defense World
Stocks In Play: Fennec Pharmaceuticals Inc. By Baystreet.ca - Investing.com Canada
Fennec Pharmaceuticals (TSE:FRX) Trading Down 0.3% – Time to Sell? - Defense World
Fennec Pharmaceuticals (TSE:FRX) Stock Price Down 0.3%Time to Sell? - MarketBeat
Fennec Pharmaceuticals Inc (FRX-T) QuotePress Release - The Globe and Mail
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference - The Manila Times
Fennec Pharmaceuticals to Present at H.C. Wainwright Fireside Chat Series - StockTitan
Where are the Opportunities in (FENC) - Stock Traders Daily
Fennec Pharmaceuticals director Raykov Rosty sells shares worth $4,807 - Investing.com
Fennec Pharmaceuticals director Raykov Rosty sells shares worth $4,807 By Investing.com - Investing.com Nigeria
Insider Sell: Rosty Raykov Sells Shares of Fennec Pharmaceuticals Inc (FENC) - GuruFocus.com
Fennec Pharmaceuticals director sells $10,022 in stock By Investing.com - Investing.com UK
Finanzdaten der Fennec Pharmaceuticals Inc-Aktie (FENC)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.95%
2.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):